Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
Clinical trial NCT00219180 · COMPLETED
Trial details
- NCT number
- NCT00219180
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-09-01
- Enrollment
- 1797
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.